Cellusion’s lead program CLS001 (iPS cell-derived corneal endothelial cell substitutes for bullous keratopathy) was featured on NHK news.
2023.04.10
For more details, please see the following link.
NHK WORLD-JAPAN News: Researchers announce first iPS cell transplant for cornea disease
